To date donations of just over $26,000 have been raised toward our $50k challenge from Altra Industrial Motion. Altra Industrial, led by President and CEO Carl Christenson ('82 B.S., '84 M.S., Mechanical Engineering), has made a substantial challenge grant that will double every gift to the Mechanical and Industrial Engineering (MIE) Department’s Innovation Shop up to $50,000. Mr. Christenson has been a longtime supporter of the College of Engineering and a personal annual donor to the undergraduate scholarship program within the college.
On December 5, the MIE 415 Senior Capstone Design course held its end-of-semester poster contest, and the winning team of students is creating an invention to improve the quality of life for children with Pediatric Multiple Synostosis Syndrome, a rare genetic disorder characterized by multiple bone fusions involving the face, limbs, and middle ear.
The research of Mechanical and Industrial Engineering Professor Yossi Chait and his colleagues was recently featured on the UMass Research Next website in an article entitled “Patient Protocol: Improving treatment outcomes for dialysis patients.” Chait, a feedback systems engineer, is part of a multidisciplinary team that has been approved by an institutional review board to begin clinical testing of a groundbreaking new protocol for administering a key drug for managing patients in the final stage of kidney disease.
Brian is an ME alum (BS’04, PhD’09) and Founder of Therapeutic Systems LLC. Watch his TED Talk!
Alexana Cranmer of the Mechanical and Industrial Engineering Department is the 2013-14 recipient of the Kenneth A. Lloyd Fellowship, awarded annually to a qualified incoming doctoral student in the MIE department who shows exceptional potential for success in his or her field, with a preference given to female applicants. Mr. Lloyd of Duxbury, Massachusetts, graduated from the College of Engineering in 1973, having majored in mechanical engineering. He is currently the vice president and general manager of Electro Switch Corporation in Weymouth, Massachusetts.
On October 30, RailPod, a startup company founded by College of Engineering alumni Brendan English (B.S. 1999 in Computer Systems Engineering) and Blair Morad (B.S. 1998 in Mechanical Engineering), won $100,000 in the 2013 MassChallenge (masschallenge.org), the world’s largest startup accelerator. RailPod was one of five $100,000 first-prize winners out of 128 companies competing in the MassChallenge.
College of engineering undergraduates Gabriel Abreu, a Mechanical Engineering major, and Xuyen Mai, of the Civil and Environmental Engineering Department, have been selected to share one of the Salute to Service Student Scholarships, which will be recognized on November 20 during a special awards event at the Boston Harbor Hotel as hosted by the UMass Amherst Alumni Association. “The Salute to Service Scholarship promotes the participation and success of students in extending their skill and talent through contributions toward the greater good of society,” explains the Alumni Association.
MIE Alumni Breakfast and Networking Event
Friday November 15
7:30 a.m. – 9:00 a.m.
The College of Engineering is planting a foot in the future by offering an online M.S. in Engineering Management. Many alumni may recognize elements in the new online program that resemble the highly successful Video Instructional Program, known affectionately as VIP, which was a mainstay for three decades in the College of Engineering. The times have changed, and the capabilities have dramatically increased since the VIP program was first started.
Professor Yossi Chait of the Mechanical and Industrial Engineering Department at the University of Massachusetts Amherst is part of a multidisciplinary team that has been approved by an institutional review board to begin clinical testing of a groundbreaking new protocol for administering a key drug for managing patients in the final stage of kidney disease. “We are developing protocols for patients who have kidney disease and are undergoing dialysis and need precise, effective doses of recombinant human erythropoietin hormone,” says Chait.